drugset / Trial / NCT02273154
Randomized，Controlled and Open-label Study of Buspirone add-on Treatment in Patients With Major Depression Disorder
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a Multicenter, open lable, parallel randomized controlled clinical trial. This study aimed to evaluate the treatment onset time, efficacy and safety in patients with major depressive disorders , accompanying anxiety receiving Buspirone and Paroxetine.
Timeline
- Start
- 2014-08
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buspirone | Small molecule | 10 mg | — |
| Background | Paroxetine | Small molecule | 20 mg | — |
| Background | Paroxetine | Small molecule | 60 mg | — |